Triacylglycerols (TGs) are quantitatively the most important storage form of energy for eukaryotic cells, and TG synthesis plays an important role in metabolism in the intestine, liver, mammary gland, and adipose tissue. TGs are synthesized from fatty acyl CoA and diacylglycerol, which can be derived from the glycerol-3-phospate pathway or, in intestinal enterocytes, from monoacylglycerol. The enzyme acyl CoA:diacylglycerol acyltransferase (DGAT) has long been recognized as a key enzyme in TG synthesis and has been thought to catalyze the terminal and only committed step in the pathway. We recently cloned a DGAT gene and now have inactivated this gene in mice. Surprisingly, the DGAT knockout mice are viable and have normal plasma TGs and significant amounts of TGs in adipose tissue, revealing that an additional mechanism for TG synthesis exists. Importantly, another mechanism must participate in TG synthesis for incorporation into lipoproteins. Additionally, although they have adipose tissue, DGAT-deficient mice are leaner than their chow-fed littermates and are resistant to developing obesity when they are fed a high-fat diet. This finding has identified DGAT inhibition as a possible strategy for treating obesity. This revised proposal has three major aims.
Specific Aim 1 is to determine the expression pattern and regulation of DGAT. We will determine the tissue expression pattern of DGAT mRNA and protein by techniques such as immunoblotting and immunohistochemistry, and we will examine the regulation of DGAT mRNA and protein expression levels in response to metabolic perturbations.
Specific Aim 2 is to investigate further the in vivo functions of DGAT. Specifically, we will determine: 1) the mechanism for the leanness and obesity resistance in DGAT knockout mice, 2) whether DGAT deficiency protects against obesity and insulin resistance syndromes caused by genetic mutations, and 3) the effects of DGAT deficiency on the synthesis and secretion of intestinal chylomicrons and hepatic very low density lipoproteins.
Specific Aim 3 is to identify and clone a second DGAT enzyme or other enzymes that catalyze TG synthesis. We will analyze the biochemistry of alternative pathways of TG synthesis in DGAT- deficient tissues such as the small intestine, liver, and adipose tissue, and in Dgat-/- fibroblasts. Additionally, we will use a retrovirus-based expression cloning strategy in Dgat-/-, fibroblasts to identify and clone genes that augment TG synthesis. The proposed studies should yield important new information concerning triacylglycerol synthesis in mammals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK056084-01A1
Application #
6090826
Study Section
Metabolism Study Section (MET)
Program Officer
Laughlin, Maren R
Project Start
2000-05-01
Project End
2004-04-30
Budget Start
2000-05-01
Budget End
2001-04-30
Support Year
1
Fiscal Year
2000
Total Cost
$383,963
Indirect Cost
Name
J. David Gladstone Institutes
Department
Type
DUNS #
047120084
City
San Francisco
State
CA
Country
United States
Zip Code
94158
Walther, Tobias C; Chung, Jeeyun; Farese Jr, Robert V (2017) Lipid Droplet Biogenesis. Annu Rev Cell Dev Biol 33:491-510
Gluchowski, Nina L; Chitraju, Chandramohan; Picoraro, Joseph A et al. (2017) Identification and characterization of a novel DGAT1 missense mutation associated with congenital diarrhea. J Lipid Res 58:1230-1237
Gluchowski, Nina L; Becuwe, Michel; Walther, Tobias C et al. (2017) Lipid droplets and liver disease: from basic biology to clinical implications. Nat Rev Gastroenterol Hepatol 14:343-355
Chitraju, Chandramohan; Mejhert, Niklas; Haas, Joel T et al. (2017) Triglyceride Synthesis by DGAT1 Protects Adipocytes from Lipid-Induced ER Stress during Lipolysis. Cell Metab 26:407-418.e3
Mul, Joram D; Begg, Denovan P; Haller, April M et al. (2014) MGAT2 deficiency and vertical sleeve gastrectomy have independent metabolic effects in the mouse. Am J Physiol Endocrinol Metab 307:E1065-72
Krahmer, Natalie; Farese Jr, Robert V; Walther, Tobias C (2013) Balancing the fat: lipid droplets and human disease. EMBO Mol Med 5:973-83
Shimazu, Tadahiro; Hirschey, Matthew D; Newman, John et al. (2013) Suppression of oxidative stress by ?-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339:211-4
Klemm, Robin W; Norton, Justin P; Cole, Ronald A et al. (2013) A conserved role for atlastin GTPases in regulating lipid droplet size. Cell Rep 3:1465-75
Currie, Erin; Schulze, Almut; Zechner, Rudolf et al. (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18:153-61
Wilfling, Florian; Wang, Huajin; Haas, Joel T et al. (2013) Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. Dev Cell 24:384-99

Showing the most recent 10 out of 44 publications